Skip to main content
PVgenix logo
Guide

AI in Pharmacovigilance: What Actually Works, and What Should Not

AI in pharmacovigilance is neither the transformation vendors imply nor the risk sceptics fear. It is genuinely good at a specific set of clerical tasks and structurally unsuitable for the regulated determinations. Knowing which is which is the whole discipline.

PVgenix13 min read

Pharmacovigilance has an unusually clean split between work that is clerical and work that is judgement, and the split maps almost exactly onto where AI is useful and where it is not. Reading a PDF and transferring patient age, product, dose and event into structured fields is clerical. Deciding whether a drug caused an event, and whether that event is listed in the product information in force, is judgement with regulatory accountability attached.

Most confusion about AI in this field comes from vendors and buyers talking about the two halves as if they were one thing. This guide separates them, explains why the boundary is a design property rather than a policy preference, and sets out how to evaluate what a vendor is actually offering.

Scope, and a disclosure

We build a pharmacovigilance platform with AI-assisted features, so weigh our perspective accordingly — this guide is written to be useful even if you never evaluate us. It is not regulatory advice. Regulatory expectations around AI in regulated processes are evolving and differ by jurisdiction, so confirm current requirements applicable to you with your qualified PV personnel and QA function rather than relying on any vendor's summary.

These are the tasks where the value is real and measurable. What they have in common: the output can be checked against a source, the cost of an error caught in review is low, and the work scales linearly with case volume — which is precisely the work that consumes qualified people's time.

01
Extraction from unstructured sources

Pulling patient, product, event, lab and reporter data out of PDFs, emails and free-text narratives. Verifiable against the source document, high volume, and pure transcription — the strongest single use case.

02
MedDRA coding proposals

Suggesting terms for reported verbatim text, handling synonyms, misspellings and phrasing variation. A proposal a coder accepts or overrides, not a decision.

03
Literature screening and triage

Reducing a thousand search hits to a reviewable few by relevance, and flagging candidate ICSRs for confirmation. High volume, low individual stakes, human confirmation at the end.

04
Duplicate candidate detection

Scoring an inbound report against the existing case population where fields are partial and inconsistently formatted — exactly the fuzzy matching problem rules alone handle badly.

05
Narrative drafting

Producing a first-draft narrative from structured case data for a reviewer to edit. Saves composition time; the reviewer still owns the content.

06
Routing and prioritisation support

Classifying inbound reports to route them. Note that the routing decision itself is better served by deterministic rules — see below.

The determinations below share three properties that make autonomous AI unsuitable: they carry regulatory accountability that must rest with a person, they require reasoning that has to be explainable years later, and being wrong is not a correctable data-entry error but a compliance event.

DeterminationWhy it must stay human
Causality assessmentRequires weighing temporality, alternative explanations, dechallenge and rechallenge, and clinical plausibility — and the assessor is accountable for the conclusion
Expectedness / listednessDepends on comparing the event against a specific version of the reference safety information in force on a specific date; the consequence is expedited reportability
Seriousness sign-offIncludes the "other medically important" criterion, which is an explicit clinical judgement with no mechanical definition
Case validityBorderline patient and reporter identifiability calls determine whether a regulated case exists at all
Duplicate merge decisionsMerging is effectively irreversible and can silently destroy new information — the failure nobody notices
Release to submissionThe point at which your organisation asserts a regulatory position to an authority
Benefit-risk conclusionsThe interpretive core of a periodic report; the reasoning, not just the conclusion, is what is assessed
The regulated determinations, and why each resists autonomous automation.

The question that exposes a weak AI implementation

Ask a vendor: "Can the system be configured so that AI sets causality, or closes a serious case, without a person?" The answer you want is that it structurally cannot — not "we recommend against configuring it that way". A guardrail that depends on configuration discipline is a guardrail that will eventually be turned off by someone under deadline pressure.

"Human oversight" is the easiest claim in the category to make and the hardest to evidence. In a GxP context it needs to be structural, and there are four mechanisms that make it so.

  1. **AI proposes, a person disposes.** The AI output has no effect on the regulated record until a qualified user accepts it. Nothing reaches submission on a model's authority.
  2. **Per-field confidence, not per-case confidence.** A single confidence score for a whole case is close to useless operationally. Per-field scoring is what lets you route only the uncertain items to review instead of re-reading everything or trusting everything.
  3. **Evidence presented alongside the output.** A reviewer should see the extracted value next to its source context, so they verify against the document rather than assessing whether the AI looks confident.
  4. **The audit trail records the whole chain.** What was proposed, what confidence was assigned, what the reviewer changed, who approved it, and when — so the decision chain is reconstructable by someone who was not there.

The principle, stated plainly

AI assists intake and data entry. Qualified personnel review, edit, and approve AI-generated content before a case proceeds; regulated judgments remain with the client's PV personnel.

An under-discussed point: not everything that could be automated should be automated with a model. Some outcomes must be repeatable and explainable, and for those a configurable rules engine is the better instrument — not because models are unreliable, but because "the same inputs always produce the same output, and here is the rule" is a requirement in itself.

TaskBetter instrumentWhy
Extraction from a PDFAIUnstructured, endlessly variable input; verifiable output
Reportability determinationRulesMust be repeatable, explainable and change-controlled; encodes regulatory interpretation you own
Day 0 and deadline calculationRulesA deterministic derivation with compliance consequences
Which authority receives which formatRulesConfiguration you approve, not inference
Coding proposalAILanguage variation is the problem; a coder confirms
Literature relevance screeningAIVolume reduction with human confirmation at the end
Duplicate scoringBothDeterministic rules for near-exact matches, fuzzy matching for the rest — surfaced as candidates
Which mechanism suits which job.

See the reporting rules engine for how deterministic rules resolve obligations, and AI MedDRA coding for where inference genuinely helps.

Straight-through or touchless processing — a case moving through the workflow with reduced manual intervention — is a reasonable capability and a genuine efficiency gain. It becomes a risk when its scope is implicit rather than decided.

  • Scope it to defined, low-risk case types — typically listed, non-serious events on established products, never serious or fatal cases
  • Set the confidence thresholds yourself, per product and case type, and document the rationale
  • Keep human review as the default rather than the exception, so the automated path is the carve-out
  • Monitor it: sample automated cases and track the error rate found, with a trigger that narrows scope if it drifts
  • Be able to explain the scope decision at an inspection as a documented risk assessment, not a vendor default you inherited

This is the concern that stops many teams, and the human-in-the-loop design is what makes it tractable. If AI output only ever enters the regulated record through a review-and-approval gate you already qualify, then the control you are qualifying is the gate — the same control that governs manual data entry.

  • Establish which steps are AI-assisted and document them in your process description — an inspector should not have to discover this
  • Confirm AI-assisted steps are captured in the audit trail to the same standard as manual ones
  • Qualify the review gates and the confidence-routing configuration, since those are the controls doing the work
  • Treat threshold and scope changes as change-controlled configuration changes with a documented approval
  • Keep deterministic outcomes (reportability, deadlines, routing) rule-based so they can be tested by expected-result cases
  • Include AI-assisted paths explicitly in your performance qualification, including a low-confidence case being caught and corrected

Validation is environment-specific

PVgenix is validation-ready and audit-ready: it ships with a complete IQ/OQ/PQ documentation package to support client-led validation. 'Validated' is a state achieved only after qualification is executed in a specific client environment.

Every safety platform now says it has AI, which makes the claim itself uninformative. These questions separate implementations that hold up from demos that look good. Ask them of every vendor, including us.

AskWhat a good answer looks like
Which specific steps are AI-assisted, and which are rules-based?A precise list, with reportability and deadlines on the rules side
Is confidence scored per field or per case?Per field, with automatic routing of low-confidence items to review
Can AI ever set causality, expectedness or seriousness sign-off?No — structurally, not by recommendation
What does the audit trail record about an AI-assisted step?Proposal, confidence, reviewer change, approver, timestamp
How is straight-through processing scoped and controlled?Client-configured per case type, with human review as the default and monitoring in place
Show me a low-confidence extraction being caught and corrected — live.Done in the demo, on a real screen, in a minute
Is the extracted value shown alongside its source context?Yes — the reviewer verifies against the document, not against the model
How do we test AI-assisted steps during qualification?A concrete approach, including expected-result cases through the review gate
What happens when the model is updated?A change-control and notification process, with re-testing expectations stated
A vendor-neutral AI evaluation checklist.

For how PVgenix answers each of these, see AI pharmacovigilance software and the extraction and review console on AI case intake.

Two honest caveats worth holding onto when a business case is being built.

  • Extraction accuracy varies by source quality, document type and field. A clean structured form and a scanned handwritten fax are not the same problem, and any single headline accuracy figure hides that variance — which is exactly why per-field confidence scoring matters more than an accuracy claim.
  • Review effort does not go to zero. It is redirected: from typing everything to verifying the uncertain and assessing the clinical picture. The gain is real, but a business case built on eliminating review will not survive contact with a serious case.

The short version

Use AI for extraction, coding proposals, literature screening, duplicate candidates and narrative drafts — the clerical, verifiable, high-volume work. Use deterministic rules for reportability, deadlines and routing, where repeatability is the requirement. Keep causality, expectedness, seriousness sign-off and release with qualified people, enforced structurally rather than by policy. Score confidence per field, present evidence alongside output, and log the whole chain.

Next in this cluster: AI versus manual ICSR processing for where the time and money actually go, and AI MedDRA coding explained for the mechanics of the single most-automated step.

AI in pharmacovigilanceartificial intelligence drug safetyhuman-in-the-loop pharmacovigilanceAI adverse event processingAI PV automationmachine learning pharmacovigilance

Frequently asked questions

Common questions

See PVgenix on your case types

Request a demo to walk through intake, AI-assisted processing, and human-in-the-loop review on your own scenarios.